Prof Gillian Queisser has been awarded the four year grant NMDAR/TRPM4 signaling and mitochondrial dysfunction in Alzheimer’s Disease. The project studies mechanisms of neurotoxicity and cognitive decline in neurodegenerative diseases with special emphasis on Alzheimer's disease, and develops mathematical multiscale models ranging from the ultrastructural organization of membrane receptors to the functional cellular scale will be guided by cutting-edge microscopy techniques. Ultimately, the goal is to identify druggable targets and diagnostic tools relevant to Alzheimer research.